Coastal Pediatric Associates

Mt. Pleasant, South Carolina 29464

0 studies enrolling now · 4 studies all time

What they study most

Attention Deficit Hyperactivity Disorder (ADHD), Cough

Studies at this site

• Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years — Completed
• Dextromethorphan Pediatric Acute Cough Study — Stopped early